+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Factor XIII in bronchoalveolar lavage fluid from children with chronic bronchoalveolar inflammation



Factor XIII in bronchoalveolar lavage fluid from children with chronic bronchoalveolar inflammation



Journal of Thrombosis and Haemostasis 3(7): 1407-1413



Extravascular activation of the coagulation system and consequent fibrin deposition is involved in the pathomechanism of chronic bronchoalveolar inflammatory diseases. The turnover of extravascular fibrin is attenuated by its cross-linking with activated factor XIII (FXIII). Determination of cellular and plasmatic forms of FXIII and their correlation with D-dimer level in the bronchoalveolar lavage fluid (BALF) from healthy children and from children with bronchoalveolar inflammation. Highly sensitive immunoassays were used for the quantitation of cellular and plasma FXIII and D-dimer in the BALF of children with recurrent wheezy bronchitis and fibrosing alveolitis. BALF was investigated for FXIII-containing cells by flow cytometry. In the BALF of controls a low amount of the cellular form of FXIII (FXIII A2) and D-dimer were measured, while plasma FXIII (FXIII A2B2) was absent. Alveolar macrophages represented the single cell population in BALF that contained FXIII. In the BALF of both patients' groups the concentration and the total amount of FXIII A2 was significantly elevated, and plasma FXIII also appeared in the BALF of most patients. The D-dimer concentration was also elevated in the patients' groups and it correlated both with plasma FXIII and neutrophil count. These findings suggest that FXIII A2 is released from activated or injured alveolar macrophages into the bronchoalveolar lining fluid and in bronchoalveolar inflammatory diseases, FXIII A2B2 also leaks out from the capillaries. By cross-linking fibrin and inhibitors of fibrinolysis to fibrin, FXIII might be a key regulator of fibrin turnover in the extravascular compartment.

(PDF emailed within 0-6 h: $19.90)

Accession: 049057769

Download citation: RISBibTeXText

PMID: 15892856

DOI: 10.1111/j.1538-7836.2005.01353.x


Related references

Monocyte chemotactic and activating factor/monocyte chemoattractant protein in bronchoalveolar lavage fluid from patients with atopic asthma and chronic bronchitis. Relationship to lung function tests, bronchial hyper-responsiveness and cytology of bronchoalveolar lavage fluid. Immunology Letters 58(1): 47-52, 1997

Fibronectin in bronchoalveolar lavage fluid and plasma from children with chronic inflammation of lungs. Acta Paediatrica Scandinavica 77(5): 727-733, 1988

Studies on respiratory diseases by bronchoalveolar lavage fluid part 2. evaluation of granulocyte function in bronchoalveolar lavage fluid. Okayama Igakkai Zasshi 99(9-10): 1223-1238, 1987

Studies on respiratory diseases by bronchoalveolar lavage fluid part 1. estimation of immunoglobulins and histamine in bronchoalveolar lavage fluid. Okayama Igakkai Zasshi 99(9-10): 1205-1222, 1987

The bronchoalveolar lavage bal a diagnostic tool in chronic nonspecific bronchopulmonary diseases of childhood? part 2 investigations of cellular and humoral parameters of bronchoalveolar fluid. Zeitschrift fuer Erkrankungen der Atmungsorgane 176(1): 7-20, 1991

Comparison of cytokine mRNA expression in the bronchoalveolar lavage fluid of horses with inflammatory airway disease and bronchoalveolar lavage mastocytosis or neutrophilia using REST software analysis. Journal of Veterinary Internal Medicine 26(1): 153-161, 2012

Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function. Bronchoalveolar lavage for the evaluation of anti-inflammatory treatment (BEAT) study group. European Respiratory Journal 15(1): 141-145, 2000

Bronchoalveolar lavage fluid gelatinolytic activities in allergen-induced chronic lung inflammation in mice. European Respiratory Journal Supplement 9(23): 148S, 1996

Increase in markers of inflammation in bronchoalveolar lavage fluid obtained from babies who develop chronic lung disease of prematurity. European Respiratory Journal 7(SUPPL 18): 147S, 1994

Immunoglobulin levels in bronchoalveolar lavage fluid of children with chronic chest disease. Pediatric Pulmonology 29(6): 443-451, 2000

Transforming growth factor-beta(1) in bronchoalveolar lavage fluid from children with cystic fibrosis. Pediatric Pulmonology 44(11): 1057-1064, 2010

Diagnostic significance of protein levels in the bronchoalveolar lavage fluid in children with chronic pneumonia. Pediatriia 1990(8): 108-109, 1990

Studies of hepatocyte growth factor in bronchoalveolar lavage fluid in chronic interstitial lung diseases. Polskie Archiwum Medycyny Wewnetrznej 125(4): 260-271, 2017

Airway inflammation in menopausal women with chronic irritating cough Study of the cell-population and lymphocyte subsets in the bronchoalveolar lavage fluid by flow cytometry. European Respiratory Journal Supplement 10(25): 60S, Sept, 1997

Chemotactic monocyte and activation factor (MCAF/MCP1)in material from bronchoalveolar lavage fluid of patients with chronic bronchitis. Polski Merkuriusz Lekarski 2(12): 363-365, 1997